Geode Capital Management, LLC Maia Biotechnology, Inc. Put Options Transaction History
Geode Capital Management, LLC
- $1.39 Trillion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding MAIA
# of Institutions
22Shares Held
2.26MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.14MShares$1.89 Million0.0% of portfolio
-
Centric Wealth Management573KShares$951,8400.26% of portfolio
-
Black Rock Inc. New York, NY78.5KShares$130,3440.0% of portfolio
-
State Street Corp Boston, MA75.6KShares$125,4130.0% of portfolio
-
Northern Trust Corp Chicago, IL39KShares$64,7930.0% of portfolio
About MAIA Biotechnology, Inc.
- Ticker MAIA
- Exchange
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,935,900
- Market Cap $18.2M
- Description
- MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...